An Observational Outcomes Study for Autologous Cell Therapy Among Patients With COPD and Interstitial Lung Disease

CompletedOBSERVATIONAL
Enrollment

489

Participants

Timeline

Start Date

January 3, 2017

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions
COPDInterstitial Lung Disease
Interventions
PROCEDURE

Cell therapy

Each participant will receive cell therapy with stem cells harvested either from peripheral blood or from bone marrow plus peripheral blood; after harvest, cells are processed and returned to the patient via peripheral circulation on the same day

Trial Locations (1)

75231

Lung Institute Dallas, Dallas

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Lung Institute

INDUSTRY